Apr 24 |
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
|
Apr 9 |
Cantor starts Structure at overweight, sees positive data for GLP-1 drug
|
Mar 30 |
7 Small-Cap Stocks that Wall Street Loves for Good Reason
|
Mar 10 |
We Think Structure Therapeutics (NASDAQ:GPCR) Can Afford To Drive Business Growth
|
Mar 8 |
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference
|
Mar 8 |
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights
|
Jan 22 |
Here’s Why Structure Therapeutics (GPCR) Fell in Q4
|
Dec 25 |
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
|
Dec 22 |
7 Small-Cap Stocks That Wall Street Loves for Good Reason
|
Dec 19 |
Structure Therapeutics And Its Unstructured Weight Loss Data
|